CANNABIS DEAL MAKING CONTINUES TO STRUGGLE AS CASH CRUNCH INTENSIFIES In our Dec. 18, 2019, Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. Capital market trends in 1H20 validate our thesis. Data from Viridian Capital Advisors shows that [...]
RUSSELL 3000 REBALANCING SETS STAGE FOR GREATER INSTITUTIONAL OWNERSHIP OF CANNABIS NAMES We believe the inclusion of GrowGeneration Corp. (GRWG) and Akerna (KERN) in the Russell 3000 index is indicative of the rising interest of institutional investors in the cannabis space. GrowGeneration, the largest chain of stand-alone specialty hydroponic and organic garden centers in the U.S., [...]
AURORA CANNABIS (ACB) IS UP 176% IN TWO WEEKS; WILL THE RALLY SUSTAIN? The acquisition of U.S. hemp retailer Reliva LLC gives Aurora Cannabis (ACB) a foothold into the $24 billion U.S. CBD market and is one of the key catalysts of the sharp appreciation in ACB’s stock price over the last couple of weeks. On [...]
SAFE BANKING ACT: ONE STEP CLOSER TO REALITY The passage of the SAFE Banking Act by the U.S. House of Representatives as part of the $3 trillion coronavirus stimulus bill suggests that cannabis legalization is moving from being a socio-political issue to an economic one. On Friday May 14, the U.S. House of Representatives passed – [...]
CANNABIS 2.0 IS HERE AND COVID-19 IS ACCELERATING THE TRANSITION Market share gains for marijuana products like edibles and vapor pens in Canada suggest that the transition from Cannabis 1.0 to Cannabis 2.0 is happening at a rapid pace, with stay-at-home restrictions imposed due to COVID-19 acting as an additional catalyst. The launch of cannabis products [...]
CANOPY GROWTH CORP (CGC): THE SECOND COMING OF THE CANNABIS BELLWETHER We believe Constellation Brands’ (STZ) purchase of an additional stake in Canopy Growth Corp. (CGC) reaffirms investors’ faith in the cannabis legalization story. On May 1, global beer, wine, and spirits major Constellation Brands exercised an aggregate of 18.8 million warrants to purchase additional shares [...]
COVID-19 IS A NET POSITIVE FOR CANNABIS. HERE’S WHY. COVID-19’s impact on the cannabis industry is more positive than negative. While COVID-19 is a net negative for most industries, cannabis is among those where the net impact is positive. There are three reasons that bring us to this conclusion: 1) emergence of cannabis as an essential/staple, [...]
CANNABIS: THE NEW ESSENTIAL Cannabis’ “essential” designation will drive sales higher even during the COVID-19 pandemic. We discussed in last week’s Stash report how cannabis sales saw a sharp surge in March as part of consumers’ stay-at-home strategy. These sales are likely to be boosted further by the classification of marijuana – especially medical marijuana – [...]
BIG BRANDS KEY CONTENDERS FOR THE BILLION-DOLLAR CBD BEAUTY OPPORTUNITY Driven by cannabidiol’s (CBD) wellness and cosmetic benefits, the U.S. CBD Beauty market is expected to grow to $1 billion+ in annual sales by 2025. Overall CBD sales in the U.S. are expected to grow from $1.8 billion in 2018 to $20 billion+ by 2024, according [...]
CANNA FINANCE: SET TO EMERGE FROM THE TROUGH OF DISILLUSIONMENT? In our Dec. 18, 2019 Stash report, we said that balance sheet strength will matter more than ever in 2020 as the cannabis industry funding environment tightens and deals dry up. We expand on this subject this week by analyzing how cannabis companies went from being [...]
